The consequences of the COVID-19 pandemic on overweight and obese people
Article Sidebar
Main Article Content
Abstract
Obesity has been considered in multiple pandemics as a serious factor due to all that it entails pathophysiologically speaking (hypercoagulable state, low grade inflammatory response and hyperactivity of the Renin Angiotensin Aldosterone System). The confinement caused by the increase in the number of cases of SARS-CoV-2 infection (Coronavirus type 2 causing Severe Acute Respiratory Syndrome) was the trigger for the acceleration and later, maintenance of the rates, worldwide, of overweight and obesity through negative changes in diet, the decrease in physical activity, the misuse of new technologies and what negative emotions and mental disorders entail. Those who already had a high Body Mass Index deteriorated impressively their condition and with it, they have reduced the years to present a Non-Communicable Disease, so much so that currently in our country again the Acute Myocardial Infarction is the first cause of mortality. For several researchers, the genesis of poor eating habits during the COVID-19 era is found in the mental health crisis, which includes increased levels of stress, anxiety and depression, as well as a negative body image. Therefore, this paper conducted the search for more recent articles, the consequences brought about in lifestyle by the COVID-19 pandemic, with emphasis on overweight and obese people COVID-19, mental health, habits, food security, physical inactivity.
Downloads
Article Details
Citas en Dimensions Service
References
Almonacid-Fierro, A. y González-Almonacid, J. (2022). Obesidad Infantil: repercusiones post-pandemia y el factor escuela. Andes pediatr, 93(3), 440-441. http://dx.doi.org/10.32641/andespediatr.v93i3.4349
Barrea, L., Vetrani, C., Caprio, M., Cataldi, M., El Ghoch, M., Elce, A., et al. (2022). From the Ketogenic Diet to the Mediterranean Diet: The Potential Dietary Therapy in Patients with Obesity after CoVID‑19 Infection (Post CoVID Syndrome). Current Obesity Reports, 11, 144-165. https://doi.org/10.1007/s13679-022-00475-z
Bozzola, E., Barney, S. & Ficariy, A. (2023). Physical Activity in the COVID-19 Era and Its Impact on Adolescents’ Well-Being. Int. J. Environ. Res. Public Health, 20(4), 3275. https://doi.org/10.3390/ijerph20043275
Bretóna, I., Holanda, A., Vilarrasac, N., Rubio, M., Lecubee, A. y Herrera, R. (2021). Obesidad y COVID-19. Un posicionamiento necesario. Endocrinología, Diabetes y Nutrición, 68(8), 573–576. https://doi.org/10.1016/j.endinu.2021.02.001
Cava, E., Neri, B., Carbonelli, M., Riso, S. & Carvone, S. (2021). Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations. Clinical Nutrition, 40(4), 1637-1643. https://doi.org/10.1016/j.clnu.2021.02.038
Czepczor-Bernat, K., Modrzejewska, A., Modrzejewska, J. & Pekaka, M. (2022). A preliminary study of body image and depression among adults during COVID-19: A moderation model. Archives of Psychiatric Nursing, 36, 55-61. https://doi.org/10.1016/j.apnu.2021.11.001
Echeverría, M., Galárraga, N., Muñoz, M., Duque, R. y Cadena-Palacios C. (2023). Sobrepeso en el periodo post confinamiento por la pandemia COVID-19. Ciencia Latina Revista Científica Multidisciplinar, 7(2), 1832-1853. https://doi.org/10.37811/cl_rcm.v7i2.5441
Fabin-Czepiel, K., Pieczyńska-Chapuła, K. & Deja, G. (2023). “The obesity pandemic” in the COVID-19 pandemic – new treatment for an old problem. Pediatr Endocrinol Diabetes Metab, 29(2), 104-111. https://doi.org/10.5114/pedm.2023.129342
Giorgino, F., Bhana, S., Czupryniak, L., Dagdelen, S., Galstyan, G., Janez, A., et al. (2021). Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa. Diabetes Research and Clinical Practice, 172, 1-10. https://doi.org/10.1016/j.diabres.2020.108617
Grosso, G. (2021). Obesity during COVID-19: An underrated pandemic? EclinicalMedicine, 39, 2589-2590. https://doi.org/10.1016/j.eclinm.2021.101062
Guglielmi, V., El Ghoch, M., Bettini, S. & Holly, J. (2022). Editorial: Covid-19 and obesity. Front Endocrinol, 13, 01-03. https://doi.org/10.3389/fendo.2022.1122274
Hassan, T., Sáenz, J., Ducinskiene, D., Cook, J., Imperato, J. & Zou, K. (2021). New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review. J Multidiscip Healthc, 14, 2453-2465. DOI: 10.2147/JMDH.S313626
Herrera, J. y Delgado, D. (2021). Obesidad y COVID-19: un panorama general. Psic-Obesidad, 10(40), 5-15. https://www.revistas.unam.mx/index.php/psic/article/view/80499
Instituto Nacional de Estadística y Geografía (INEGI) (2024). Estadísticas de defunciones registradas. De enero a junio de 2023. https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2024/EDR/EDR2023_En-Jn.pdf´
Jie Chua, M. (2021). Managing patients with obesity in the post COVID-19 world: Time to sharpen the saw. Obesity Research & Clinical Practice, 15(1), 85-88. https://doi.org/10.1016/j.orcp.2020.11.008
Kiess, W., Kirstein, A., Stein, R. & Vogel, M. (2022). Obesity after the Covid-19 pandemic and beyond. Pediatr Endocrinol Metab, 35(2), 135-138. https://doi.org/10.1515/jpem-2022-2135
Kissin, R., Khoury, L., Wallenborn, G. & Kothari, S. (2023). When the COVID-19 pandemic collides with the obesity epidemic in the United States: a national survey. Surgery for Obesity and Related Diseases, 19(5), 434-439. https://doi.org/10.1016/j.soard.2023.02.020.
Leeuw, A., Oude, M., Wellen, A., Muller, C. & Calkhoven, C. (2021). Obesity and its impact on COVID-19. Journal of Molecular Medicine, 99(7), 899–915. https://doi.org/10.1007/s00109-021-02072-4
Melamed, O., Selby, P. & Taylor, V. (2022). Mental Health and Obesity During the COVID-19 Pandemic. Current Obesity Reports, 11(1), 23-31. https://doi.org/10.1007/s13679-021-00466-6
Mosallami, S., Ebrahimpur, M., Arjmand, B., Shadman, Z., Pejman, M., Qorbani, M., et al. (2021). Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis. International Journal of Obesity, 45(5), 998-1016. https://doi.org/10.1038/s41366-021-00776-8
Pacheco-Pantoja, E., Ferreyro-Bravo, F. y Ceballos-Cruz, A. (2020). COVID-19, diabetes, obesidad e hipertensión arterial: 60 días de pandemia en México. Rev Mex Endocrinol Metab Nutr, 7(2), 68-79. https://www.revistadeendocrinologia.com/files/end_20_7_2_068-079.pdf
Rodríguez-Ramírez, S., Gaona-Pineda, E., Martínez-Tapia, B., Romero-Martinez, M., Mundo-Rosas, V. y Shamah-Levy, T. (2021). Inseguridad alimentaria y cambios en la alimentación en hogares mexicanos durante el confinamiento por la pandemia de Covid-19. Salud Pública Mex., 63(6), 763-772. https://doi.org/10.21149/12790
Rubio, M. y Bretón, I. (2021). Obesidad en tiempos de COVID-19. Un desafío de salud global. Endocrinología, Diabetes y Nutrición, 68(2), 123-129. https://doi.org/10.1016/j.endinu.2020.10.001
Sanoudou, D., Colina, M., Belanger, M., Arao, K. y Mantzoros, C. (2022). Editorial: Obesity, metabolic phenotypes and COVID-19. Metabolism, 128, 1-9. https://doi.org/10.1016/j.metabol.2021.155121
Secretaría de Salud (2023). COVID-19 México. https://datos.covid-19.conacyt.mx/
Sheth, J. (2020). Impact of Covid-19 on consumer behavior: Will the old habits return or die? Journal of Business Research, 117, 280-283. https://doi.org/10.1016/j.jbusres.2020.05.059
Stefan, N., Birkenfeld, A. & Schulze, M. (2021). Global pandemics interconnected — obesity, impaired metabolic health and COVID-19. Nature Reviews- Endocrinology. 17: 135-149. https://doi.org/10.1038/s41574-020-00462-1
Yousuf, T. & Hakan, K. (2023). Effect of the COVID-19 pandemic on obesity and its risk factors: a systematic review. BMC Public Health, 23, 1-24. https://doi.org/10.1186/s12889-023-15833-2
Zeigler, Z. (2021). COVID-19 Self-quarantine and Weight Gain Risk Factors in Adults. Current Obesity Reports, 10(3), 423-433. https://doi.org/10.1007/s13679-021-00449-7.